Problem statement: Answer the multiple-choice question.
Question: Which drug has a 15.155\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
[a] CCCN(CCC)C(=O)c1cc2c(=O)[nH]c3ccc(C)cc3c2s1
[b] CCn1c(=O)n(CC)c2cc(NC(=O)C(C)c3ccccc3)c(Br)cc21
Answer: b. CCn1c(=O)n(CC)c2cc(NC(=O)C(C)c3ccccc3)c(Br)cc21
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCn1c(=O)n(CC)c2cc(NC(=O)C(C)c3ccccc3)c(Br)cc21
CCn1c(=O)n(CC)c2cc(NC(=O)C(C)c3ccccc3)c(Br)cc21
N-(6-bromo-1,3-diethyl-2-oxobenzimidazol-5-yl)-2-phenylpropanamide